Tertensif SR 1,5 mg tablete s produljenim oslobađanjem
| Name | Tertensif SR 1,5 mg tablete s produljenim oslobađanjem |
|---|---|
| Marketing Authorisation Number | HR-H-116295639 |
| Active Substance | indapamid |
| Composition | jedna tableta s produljenim oslobađanjem sadrži 1,5 mg indapamida |
| Pharmaceutical Form | tableta s produljenim oslobađanjem |
| Manufacturer | Les Laboratoires Servier Industrie, Gidy, Francuska
Servier (Ireland) Industries Ltd., Arklow, Co. Wicklow, Irska Anpharm Przedsiebiorstwo Farmaceutyczne S.A., Varšava, Poljska |
| Marketing Authorisation Holder | Servier Pharma d.o.o., Tuškanova 37, Zagreb, Hrvatska |
| Marketing Authorisation Date | 07.12.2019 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/17-02/706 |
| Registration Number | 381-12-01/70-19-05 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product on medical prescription for renewable delivery |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | C03BA11 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
